White Papers
White papers and articles published by PharmaVentures' advisors and analysts.
Trends in the World Small Molecule API Manufacturing M&A Market
The pharmaceutical small molecule API manufacturing industry is now experiencing a period of rapid change. This paper takes a look at the trends that are helping shape mergers and acquisitions (M&A) activity within this dynamic sector.
The Strategic Importance of Biomarkers to the Pharmaceutical Industry
Pharmaceutical companies have become increasingly interested in biomarkers and their incorporation into company drug development programmes and use as companion tests for targeted therapeutics. This article looks at the value created by the addition of a biomarker into the drug development or patient identification process.
Understanding Headline Deal Values - A PharmaVentures Guide to the Interpretation of Deal Terms and Terminology
Great care must be taken when benchmarking and interpreting deal terms because the value of the deal components can sometimes be reported so as to dazzle or deceive a receptive audience. This article considers the principal deal components and provides some guidance as to their interpretation for more effective benchmarking.
Deal-making Metrics - Quantitative Trends in Partnering Transactions
This article looks at a few of the most important measures to bear in mind prior to designing deal-making strategies that any expert deal-maker executive should know about.